Advertisement

Gastric Cancer

, Volume 21, Issue 6, pp 936–945 | Cite as

Association between ALDH2 and ADH1B polymorphisms, alcohol drinking and gastric cancer: a replication and mediation analysis

  • Kuka Ishioka
  • Hiroyuki Masaoka
  • Hidemi Ito
  • Isao Oze
  • Seiji Ito
  • Masahiro Tajika
  • Yasuhiro Shimizu
  • Yasumasa Niwa
  • Shigeo Nakamura
  • Keitaro Matsuo
Original Article
  • 291 Downloads

Abstract

Background

Aldehyde dehydrogenase 2 (ALDH2; rs671, Glu504Lys) and alcohol dehydrogenase 1B (ADH1B; rs1229984, His47Arg) polymorphisms have a strong impact on carcinogenic acetaldehyde accumulation after alcohol drinking. To date, however, evidence for a significant ALDH2–alcohol drinking interaction and a mediation effect of ALDH2/ADH1B through alcohol drinking on gastric cancer have remained unclear. We conducted two case–control studies to validate the interaction and to estimate the mediation effect on gastric cancer.

Methods

We calculated odds ratios (OR) and 95% confidence intervals (CI) for ALDH2/ADH1B genotypes and alcohol drinking using conditional logistic regression models after adjustment for potential confounding in the HERPACC-2 (697 cases and 1372 controls) and HERPACC-3 studies (678 cases and 678 controls). We also conducted a mediation analysis of the combination of the two studies to assess whether the effects of these polymorphisms operated through alcohol drinking or through other pathways.

Results

ALDH2 Lys alleles had a higher risk with increased alcohol consumption compared with ALDH2 Glu/Glu (OR for heavy drinking, 3.57; 95% CI 2.04–6.27; P for trend = 0.007), indicating a significant ALDH2–alcohol drinking interaction (Pinteraction = 0.024). The mediation analysis indicated a significant positive direct effect (OR 1.67; 95% CI 1.38–2.03) and a protective indirect effect (OR 0.84; 95% CI 0.76–0.92) of the ALDH2 Lys alleles with the ALDH2–alcohol drinking interaction. No significant association of ADH1B with gastric cancer was observed.

Conclusion

The observed ALDH2–alcohol drinking interaction and the direct effect of ALDH2 Lys alleles may suggest the involvement of acetaldehyde in the development of gastric cancer.

Keywords

Alcohol drinking ALDH2 ADH1B Gastric cancer Interaction Mediation analysis 

Notes

Acknowledgements

We appreciate all the participants who have contributed to the HERPACC studies. This study was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, consisting of Priority Areas of Cancer (no. 17015018), Innovative Areas (no. 221S0001), JSPS KAKENHI Grant (nos. 16H06277, 15K08792, 26860430, 17K15841, 26253041) and by a Grant-in-Aid for the Third Term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan and the Health, and Cancer Bio Bank Aichi.

Compliance with ethical standards

Ethical approval

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.

Informed consent

Informed consent to be included in the study, or the equivalent, was obtained from all patients.

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

10120_2018_823_MOESM1_ESM.pdf (53 kb)
Supplementary material 1 (PDF 52 kb)
10120_2018_823_MOESM2_ESM.pdf (49 kb)
Supplementary material 2 (PDF 48 kb)
10120_2018_823_MOESM3_ESM.pdf (43 kb)
Supplementary material 3 (PDF 42 kb)
10120_2018_823_MOESM4_ESM.pdf (46 kb)
Supplementary material 4 (PDF 45 kb)
10120_2018_823_MOESM5_ESM.pdf (47 kb)
Supplementary material 5 (PDF 47 kb)

References

  1. 1.
    Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase no. 11 (Internet). Lyon, France: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr. Accessed 27 Nov 2017.
  2. 2.
    Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–9.CrossRefGoogle Scholar
  3. 3.
    Rahman R, Asombang AW, Ibdah JA. Characteristics of gastric cancer in Asia. World J Gastroenterol. 2014;20(16):4483–90.CrossRefGoogle Scholar
  4. 4.
    Suzuki H, Mori H. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. J Gastroenterol. 2017;53(3):354–61.CrossRefGoogle Scholar
  5. 5.
    World Cancer Research Fund International/American Institute for Cancer Research. Continuous update project report: diet, nutrition, physical activity and stomach cancer. AICR/WCRF. 2016. http://wcrf.org/sites/default/files/Stomach-Cancer-2016-Report.pdf. Accessed 27 Nov 2017.
  6. 6.
    Rota M, Pelucchi C, Bertuccio P, Matsuo K, Zhang ZF, Ito H, et al. Alcohol consumption and gastric cancer risk—a pooled analysis within the StoP project consortium. Int J Cancer. 2017;141(10):1950–62.CrossRefGoogle Scholar
  7. 7.
    Bosron WF, Li TK. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology. 1986;6(3):502–10.CrossRefGoogle Scholar
  8. 8.
    Li H, Borinskaya S, Yoshimura K, Kal’ina N, Marusin A, Stepanov VA, et al. Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant. Ann Hum Genet. 2009;73(Pt 3):335–45.CrossRefGoogle Scholar
  9. 9.
    Gross ER, Zambelli VO, Small BA, Ferreira JC, Chen CH, Mochly-Rosen D. A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant. Annu Rev Pharmacol Toxicol. 2015;55:107–27.CrossRefGoogle Scholar
  10. 10.
    Matsuo K, Wakai K, Hirose K, Ito H, Saito T, Tajima K. Alcohol dehydrogenase 2 His47Arg polymorphism influences drinking habit independently of aldehyde dehydrogenase 2 Glu487Lys polymorphism: analysis of 2,299 Japanese subjects. Cancer Epidemiol Biomark Prev. 2006;15(5):1009–13.CrossRefGoogle Scholar
  11. 11.
    Oze I, Matsuo K, Hosono S, Ito H, Kawase T, Watanabe M, et al. Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population. Cancer Sci. 2010;101(8):1875–80.CrossRefGoogle Scholar
  12. 12.
    Koyanagi YN, Ito H, Oze I, Hosono S, Tanaka H, Abe T, et al. Development of a prediction model and estimation of cumulative risk for upper aerodigestive tract cancer on the basis of the aldehyde dehydrogenase 2 genotype and alcohol consumption in a Japanese population. Eur J Cancer Prev. 2017;26(1):38–47.CrossRefGoogle Scholar
  13. 13.
    Chang JS, Hsiao JR, Chen CH. ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective. J Biomed Sci. 2017;24(1):19.CrossRefGoogle Scholar
  14. 14.
    Zhang G, Mai R, Huang B. ADH1B Arg47His polymorphism is associated with esophageal cancer risk in high-incidence Asian population: evidence from a meta-analysis. PLoS One. 2010;5(10):e13679.CrossRefGoogle Scholar
  15. 15.
    Tsai ST, Wong TY, Ou CY, Fang SY, Chen KC, Hsiao JR, et al. The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer. Int J Cancer. 2014;135(10):2424–36.CrossRefGoogle Scholar
  16. 16.
    IARC, Personal Habits and Indoor Combustions. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 100(E). Lyon: IARC; 1997.Google Scholar
  17. 17.
    Yokoyama A, Muramatsu T, Omori T, Yokoyama T, Matsushita S, Higuchi S, et al. Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis. 2001;22(3):433–9.CrossRefGoogle Scholar
  18. 18.
    Cao HX, Li SP, Wu JZ, Gao CM, Su P, Liu YT, et al. Alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes, alcohol drinking and the risk for stomach cancer in Chinese males. Asian Pac J Cancer Prev. 2010;11(4):1073–7.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Shin CM, Kim N, Cho SI, Kim JS, Jung HC, Song IS. Association between alcohol intake and risk for gastric cancer with regard to ALDH2 genotype in the Korean population. Int J Epidemiol. 2011;40(4):1047–55.CrossRefGoogle Scholar
  20. 20.
    Matsuo K, Oze I, Hosono S, Ito H, Watanabe M, Ishioka K, et al. The aldehyde dehydrogenase 2 (ALDH2) Glu504Lys polymorphism interacts with alcohol drinking in the risk of stomach cancer. Carcinogenesis. 2013;34(7):1510–5.CrossRefGoogle Scholar
  21. 21.
    Hidaka A, Sasazuki S, Matsuo K, Ito H, Sawada N, Shimazu T, et al. Genetic polymorphisms of ADH1B, ADH1C and ALDH2, alcohol consumption, and the risk of gastric cancer: the Japan Public Health Center-based prospective study. Carcinogenesis. 2015;36(2):223–31.CrossRefGoogle Scholar
  22. 22.
    Chen ZH, Xian JF, Luo LP. Analysis of ADH1B Arg47His, ALDH2 Glu487Lys, and CYP4502E1 polymorphisms in gastric cancer risk and interaction with environmental factors. Genet Mol Res. 2016;15(4).  https://doi.org/10.4238/gmr15048904.
  23. 23.
    Yang S, Lee J, Choi IJ, Kim YW, Ryu KW, Sung J, et al. Effects of alcohol consumption, ALDH2 rs671 polymorphism, and Helicobacter pylori infection on the gastric cancer risk in a Korean population. Oncotarget. 2017;8(4):6630–41.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Jorgenson E, Thai KK, Hoffmann TJ, Sakoda LC, Kvale MN, Banda Y, et al. Genetic contributors to variation in alcohol consumption vary by race/ethnicity in a large multi-ethnic genome-wide association study. Mol Psychiatry. 2017;22(9):1359–67.CrossRefGoogle Scholar
  25. 25.
    Hamajima N, Matsuo K, Saito T, Hirose K, Inoue M, Takezaki T, et al. Gene–environment interactions and polymorphism studies of cancer risk in the hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II). Asian Pac J Cancer Prev. 2001;2(2):99–107.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Hosono S, Ito H, Oze I, Watanabe M, Komori K, Yatabe Y, et al. A risk prediction model for colorectal cancer using genome-wide association study-identified polymorphisms and established risk factors among Japanese: results from two independent case–control studies. Eur J Cancer Prev. 2016;25(6):500–7.CrossRefGoogle Scholar
  27. 27.
    Imaeda N, Goto C, Tokudome Y, Hirose K, Tajima K, Tokudome S. Reproducibility of a short food frequency questionnaire for Japanese general population. J Epidemiol. 2007;17(3):100–7.CrossRefGoogle Scholar
  28. 28.
    Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels—”ABC method”. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(7):405–14.CrossRefGoogle Scholar
  29. 29.
    Sasazuki S, The ABC. Method and gastric cancer: evidence from prospective studies. J Epidemiol. 2016;26(12):611–2.CrossRefGoogle Scholar
  30. 30.
    Vanderweele TJ, Vansteelandt S. Odds ratios for mediation analysis for a dichotomous outcome. Am J Epidemiol. 2010;172(12):1339–48.CrossRefGoogle Scholar
  31. 31.
    Emsley R, Liu H. PARAMED: Stata module to perform causal mediation analysis using parametric regression models. Statistical Software Components. 2013. https://ideas.repec.org/c/boc/bocode/s457581.html. Accessed 27 Mar 2018.
  32. 32.
    Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.CrossRefGoogle Scholar
  33. 33.
    MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002;7(1):83–104.CrossRefGoogle Scholar
  34. 34.
    Valeri L, Vanderweele TJ. Mediation analysis allowing for exposure–mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods. 2013;18(2):137–50.CrossRefGoogle Scholar
  35. 35.
    Vakevainen S, Tillonen J, Agarwal DP, Srivastava N, Salaspuro M. High salivary acetaldehyde after a moderate dose of alcohol in ALDH2-deficient subjects: strong evidence for the local carcinogenic action of acetaldehyde. Alcohol Clin Exp Res. 2000;24(6):873–7.CrossRefGoogle Scholar
  36. 36.
    Yokoyama A, Tsutsumi E, Imazeki H, Suwa Y, Nakamura C, Mizukami T, et al. Salivary acetaldehyde concentration according to alcoholic beverage consumed and aldehyde dehydrogenase-2 genotype. Alcohol Clin Exp Res. 2008;32(9):1607–14.CrossRefGoogle Scholar
  37. 37.
    Maejima R, Iijima K, Kaihovaara P, Hatta W, Koike T, Imatani A, et al. Effects of ALDH2 genotype, PPI treatment and l-cysteine on carcinogenic acetaldehyde in gastric juice and saliva after intragastric alcohol administration. PLoS One. 2015;10(4):e0120397.CrossRefGoogle Scholar
  38. 38.
    Salaspuro M. Acetaldehyde and gastric cancer. J Dig Dis. 2011;12(2):51–9.CrossRefGoogle Scholar
  39. 39.
    Nagayoshi H, Matsumoto A, Nishi R, Kawamoto T, Ichiba M, Matsuda T. Increased formation of gastric N(2)-ethylidene-2′-deoxyguanosine DNA adducts in aldehyde dehydrogenase-2 knockout mice treated with ethanol. Mutat Res. 2009;673(1):74–7.CrossRefGoogle Scholar
  40. 40.
    VanderWeele TJ, Asomaning K, Tchetgen Tchetgen EJ, Han Y, Spitz MR, Shete S, et al. Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am J Epidemiol. 2012;175(10):1013–20.CrossRefGoogle Scholar

Copyright information

© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2018

Authors and Affiliations

  1. 1.Department of Pathology and Clinical LaboratoriesNagoya University Graduate School of MedicineNagoyaJapan
  2. 2.Division of Molecular and Clinical EpidemiologyAichi Cancer Center Research InstituteNagoyaJapan
  3. 3.Department of Urology, Graduate School of Medical SciencesKyushu UniversityFukuokaJapan
  4. 4.Department of EpidemiologyNagoya University Graduate School of MedicineNagoyaJapan
  5. 5.Department of Gastroenterological SurgeryAichi Cancer Center HospitalNagoyaJapan
  6. 6.Department of GastroenterologyAichi Cancer Center HospitalNagoyaJapan

Personalised recommendations